Schwarz Pharma

1 article about Schwarz Pharma

• BlackThorn Therapeutics Names George S. Golumbeski, Ph.D., to Board of Directors

  6/12/2018

  BlackThorn Therapeutics today announced the appointment of a key strategic executive to the company’s board of directors, George S. Golumbeski, Ph.D.